期刊文献+

术前冠状动脉CTA评估支架参数与PCI放置支架参数的对比研究 被引量:3

Stent Parameter of Percutaneous Coronary Intervention:Compared with Preoperative Coronary Computed Tomographic Angiography
原文传递
导出
摘要 目的对比分析术前冠状动脉CTA(CCTA)预估冠状动脉支架参数与冠状动脉介入治疗(PCI)置入支架参数的相关性与差异性。方法采用前瞻性研究方法,分析测量30例患者PCI术前1周内的CCTA图像,对其中50枚病变进行支架直径及长度的预估,并与PCI术中实际放置的50枚支架直径及长度进行比较。结果 (1)CCTA预测的支架直径及长度与PCI术中实际放置的支架直径及长度有明显的相关性(r=0.860,P<0.05;r=0.680,P<0.05);(2)CCTA预测的支架长度与PCI实际放置的支架长度差异有统计学意义(t=-2.680,P<0.05),其中CCTA预测的支架长度大于PCI实际放置的支架长度共43枚(86.0%)。结论 CCTA预测支架参数与PCI有较好的相关性,CCTA预测的支架长度往往大于PCI实际放置的支架长度,应引起临床重视。 Objective To analyze the correlation and difference of stent parameter predicted by using coronary computed tomographic angiography( CCTA) with that finally implanted in percutaneous coronary intervention( PCI). Methods Thirty patients with 50 lesions were enrolled in this prospective study. The stent diameter( CTA Stent D) and length( CTA Stent L) were evaluated by using CCTA preoperatively,and compared with the diameter( CAG Stent D) and length( CAG Stent L) finally used in PCI. Results( 1) There were significant correlations between CTA Stent D and CAG Stent D( r = 0. 860,P 〈0. 05) and between CTA Stent L and CAG Stent L( r = 0. 680,P 〈0. 05).( 2) There was significant statistical difference between the CTA Stent L and the CAG Stent L( t =- 2. 680,P 〈0. 05). In 43 lesions( 86. 0%),the lengths of CTA Stent L were longer than that of CAG Stent L. Conclusion There are significant correlation between CCTA and CAG based stent sizing in an experienced setting. The lengths of stent predicted by CCTA are longer than that of stent finally implanted,which should be a focus of clinical attention.
出处 《临床放射学杂志》 CSCD 北大核心 2015年第10期1585-1589,共5页 Journal of Clinical Radiology
关键词 CT冠状动脉造影 冠状动脉支架置入术 支架型号 Coronary computed tomographic angiography Percutaneous coronary intervention Stent
  • 相关文献

参考文献14

  • 1刘小清.冠心病流行病学研究进展及疾病负担[J].中华心血管病杂志,2008,36(6):573-576. 被引量:101
  • 2Cassese S, Byrne RA, Tada T, et al. Incidence and predictors of rest- cnosis after coronary stenting in 10 004 patients with surveillance an- giography [ J]. Heart,2014,100 : 153-159.
  • 3Ruygrok PN, Webster MW, de Valk V, et al. Clinical and angio- graphic factors associated with asymptomatic restenosis after percuta- neous aoronary intervention [ J]. Circulation, 2001,104:2289-2294.
  • 4Mohan S, Dhall A. A comparative study of restenosis rates in bare metal and drug-eluting stents[J]. Int J Angiol,2010,19 :e66-e72.
  • 5朱天刚,胡大一,陈方,贾三庆,王乐丰,李田昌,杨明.冠脉内超声成像在冠状动脉内支架植入术中的应用[J].中华超声影像学杂志,2000,9(7):395-397. 被引量:11
  • 6Stone GW, Moses JW, Ellis SG, et al. Safety and efficacy of sirolimus and paclitaxel'eluting coronary stents [ J ]. N Engl J Med, 2007, 356:998-1008.
  • 7Holmes DR, Kereiakes D J, Laskey WK, et al. Thrombosis and drug- eluting stents: An objective appraisal [ J ]. J Am Coll Cardiol,2007, 50 : 109-118.
  • 8van Velzen JE, de Graaf MA, Ciarka A, et al. Non-invasive assess- ment of atherosclerotic coronary lesion length using multidetector computed tomography angiography: comparison to quantitative coro- nary angiography [ J ]. Int J Cardiovasc Imaging, 2012,28 : 2065- 2071.
  • 9Agostoni P, Valgimigli M, van Mieghem CA, et al. Comparison of ear- ly outcome of percutaneous coronary intervention for unprotected left main coronary artery disease in the drug-eluting stentera with versus without intravascular ultrasonic guidance [ J ]. Am J Cardiol, 2005, 95,644-647.
  • 10Schoenhagen P, Nagel E. Noninvasive Assessment of Coronary Artery Disease [ J]. JACC Cardiovasc Imaging,2011,4:62-64.

二级参考文献31

  • 1王心旺,杨哲,方积乾.广东省居民6种疾病负担研究[J].广州医学院学报,2004,32(2):21-25. 被引量:22
  • 2金慧芝,宋桂香,靳文正,单正源.上海居民五种慢性非传染性疾病死亡率分析[J].中国慢性病预防与控制,1994,2(5):205-207. 被引量:11
  • 3吴兆苏,姚崇华,赵冬,吴桂贤,王薇,刘静,曾哲淳,吴英恺.我国多省市心血管病趋势及决定因素的人群监测(中国MONICA方案)Ⅰ.发病率和死亡率监测结果[J].中华心血管病杂志,1997,25(1):6-11. 被引量:205
  • 4Levenson JW, Skerrett PJ, Gaziano JM. Reducing the global burden of cardiovascular disease: the role of risk factors. Prev Cardiol, 2002,5:188-199.
  • 5Deaths from coronary heart disease. World Health Organization; 2006. Available at: http://www, who. int/cardiovascular_ diseases/en/cvd atlas 14 deathHD, pdf. Accessed July9, 2007.
  • 6卫生部信息统计中心.2006年中国卫生事业发展情况统计公报http://www.moh.gov.cn/newshtml/18903.htm[2007-7-9].
  • 7Global Strategy on Diet, Physical Activity and Health. World Health Organization; 2006. Available at: http://www, who. int/ dietphysiealaetivity/publieations/faets/evd/en/index, html. Accessed July 9, 2007.
  • 8Murray C J, Kulkarni SC, Ezzati M. Understanding the coronary heart disease versus total cardiovascular mortality paradox: a method to enhance the comparability of cardiovascular death statistics in the United States. Circulation, 2006,113 : 2071-2081.
  • 9Yusuf S, Reddy S, Ounpuu S, et al. Global burden of cardiovascular diseases: part I: general considerations, the cpidcmiologic transition, risk factors, and impact of urbanization. Circulation, 2001,104:2746-2753.
  • 10Pedoe T H, Kuulasmaa K, Mabonen M, et al. Contribution of survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Lancet, 1999,353 : 1547-1557.

共引文献110

同被引文献27

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部